Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 04-2024 | 01-2024 | 10-2023 | 07-2023 | 04-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 0 | 0 | 136 | 136 | 137 |
| Accounts receivable | -1 | -2 | 12 | 2 | -6 |
| Other Working Capital | -6 | 1 | 18 | -27 | 29 |
| Other Operating Activity | -52 | -42 | -226 | -163 | -216 |
| Operating Cash Flow | $-58 | $-43 | $-61 | $-53 | $-56 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $0 | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 59 | 40 | 63 | 17 | N/A |
| Debt Repayment | 0 | 0 | 5 | 0 | -2 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 57 |
| Financing Cash Flow | $59 | $40 | $68 | $17 | $55 |
| Beginning Cash Position | 9 | 12 | 4 | 40 | 41 |
| End Cash Position | 10 | 9 | 12 | 4 | 40 |
| Net Cash Flow | $0 | $-2 | $7 | $-36 | $-1 |
| Free Cash Flow | |||||
| Operating Cash Flow | -58 | -43 | -61 | -53 | -56 |
| Free Cash Flow | -58 | -43 | -61 | -53 | -56 |